ID   KAD2_HUMAN              Reviewed;         239 AA.
AC   P54819; A8K6L1; B4DHH7; B4DL64; Q16856; Q5EB54; Q5TIF7; Q8TCY2;
AC   Q8TCY3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   12-APR-2017, entry version 179.
DE   RecName: Full=Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168};
DE            Short=AK 2 {ECO:0000255|HAMAP-Rule:MF_03168};
DE            EC=2.7.4.3 {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   Contains:
DE     RecName: Full=Adenylate kinase 2, mitochondrial, N-terminally processed {ECO:0000255|HAMAP-Rule:MF_03168};
GN   Name=AK2 {ECO:0000255|HAMAP-Rule:MF_03168}; Synonyms=ADK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8843353;
RA   Lee Y., Kim J.W., Lee I.A., Kang H.B., Choe Y.K., Lee H.G., Lim J.S.,
RA   Kim H.J., Park C., Choe I.S.;
RT   "Cloning and characterization of cDNA for human adenylate kinase 2A.";
RL   Biochem. Mol. Biol. Int. 39:833-842(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal liver;
RX   PubMed=9504408; DOI=10.1093/oxfordjournals.jbchem.a021915;
RA   Lee Y., Kim J.W., Lee S.M., Kim H.J., Lee K.S., Park C., Choe I.S.;
RT   "Cloning and expression of human adenylate kinase 2 isozymes:
RT   differential expression of adenylate kinase 1 and 2 in human muscle
RT   tissues.";
RL   J. Biochem. 123:47-54(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9434148; DOI=10.1016/S0167-4781(97)00193-0;
RA   Noma T., Song S., Yoon Y.-S., Tanaka S., Nakazawa A.;
RT   "cDNA cloning and tissue-specific expression of the gene encoding
RT   human adenylate kinase isozyme 2.";
RL   Biochim. Biophys. Acta 1395:34-39(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RA   Guo J.;
RT   "Novel isoforms of human adenylate kinase 2.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 5 AND 6).
RC   TISSUE=Brain, Placenta, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-14; 18-34; 73-85; 94-103; 107-117 AND 120-138,
RP   CLEAVAGE OF INITIATOR METHIONINE, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-58 AND THR-195,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH BI-SUBSTRATE
RP   ANALOG AP4A, AND DISULFIDE BOND.
RA   Bunkoczi G., Filippakopoulos P., Debreczeni J.E., Turnbull A.,
RA   Papagrigoriou E., Savitsky P., Colebrook S., Von Delft F.,
RA   Arrowsmith C., Edwards A., Sundstrom M., Weigelt J., Knapp S.;
RT   "Structure of human adenylate kinase 2.";
RL   Submitted (JAN-2006) to the PDB data bank.
RN   [18]
RP   INVOLVEMENT IN RDYS, AND TISSUE SPECIFICITY.
RX   PubMed=19043417; DOI=10.1038/ng.265;
RA   Pannicke U., Hoenig M., Hess I., Friesen C., Holzmann K., Rump E.-M.,
RA   Barth T.F., Rojewski M.T., Schulz A., Boehm T., Friedrich W.,
RA   Schwarz K.;
RT   "Reticular dysgenesis (aleukocytosis) is caused by mutations in the
RT   gene encoding mitochondrial adenylate kinase 2.";
RL   Nat. Genet. 41:101-105(2009).
RN   [19]
RP   VARIANTS RDYS TRP-103 AND GLY-165, AND FUNCTION.
RX   PubMed=19043416; DOI=10.1038/ng.278;
RA   Lagresle-Peyrou C., Six E.M., Picard C., Rieux-Laucat F., Michel V.,
RA   Ditadi A., Chappedelaine C.D., Morillon E., Valensi F.,
RA   Simon-Stoos K.L., Mullikin J.C., Noroski L.M., Besse C.,
RA   Wulffraat N.M., Ferster A., Abecasis M.M., Calvo F., Petit C.,
RA   Candotti F., Abel L., Fischer A., Cavazzana-Calvo M.;
RT   "Human adenylate kinase 2 deficiency causes a profound hematopoietic
RT   defect associated with sensorineural deafness.";
RL   Nat. Genet. 41:106-111(2009).
CC   -!- FUNCTION: Catalyzes the reversible transfer of the terminal
CC       phosphate group between ATP and AMP. Plays an important role in
CC       cellular energy homeostasis and in adenine nucleotide metabolism.
CC       Adenylate kinase activity is critical for regulation of the
CC       phosphate utilization and the AMP de novo biosynthesis pathways.
CC       Plays a key role in hematopoiesis. {ECO:0000255|HAMAP-
CC       Rule:MF_03168, ECO:0000269|PubMed:19043416}.
CC   -!- CATALYTIC ACTIVITY: ATP + AMP = 2 ADP. {ECO:0000255|HAMAP-
CC       Rule:MF_03168}.
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=AK2A, AK2isoA;
CC         IsoId=P54819-1; Sequence=Displayed;
CC       Name=2; Synonyms=AK2B, AK2isoB;
CC         IsoId=P54819-2; Sequence=VSP_002790;
CC       Name=3; Synonyms=AK2C;
CC         IsoId=P54819-3; Sequence=VSP_002791;
CC       Name=4; Synonyms=AK2D;
CC         IsoId=P54819-4; Sequence=VSP_002792, VSP_002793, VSP_002794;
CC       Name=5;
CC         IsoId=P54819-5; Sequence=VSP_036503, VSP_002790;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=P54819-6; Sequence=VSP_002792;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Present in most tissues. Present at high level
CC       in heart, liver and kidney, and at low level in brain, skeletal
CC       muscle and skin. Present in thrombocytes but not in erythrocytes,
CC       which lack mitochondria. Present in all nucleated cell populations
CC       from blood, while AK1 is mostly absent. In spleen and lymph nodes,
CC       mononuclear cells lack AK1, whereas AK2 is readily detectable.
CC       These results indicate that leukocytes may be susceptible to
CC       defects caused by the lack of AK2, as they do not express AK1 in
CC       sufficient amounts to compensate for the AK2 functional deficits
CC       (at protein level). {ECO:0000269|PubMed:19043417}.
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and
CC       two small peripheral domains, NMPbind and LID, which undergo
CC       movements during catalysis. The LID domain closes over the site of
CC       phosphoryl transfer upon ATP binding. Assembling and dissambling
CC       the active center during each catalytic cycle provides an
CC       effective means to prevent ATP hydrolysis. {ECO:0000255|HAMAP-
CC       Rule:MF_03168, ECO:0000305|Ref.17}.
CC   -!- DISEASE: Reticular dysgenesis (RDYS) [MIM:267500]: A fatal form of
CC       severe combined immunodeficiency, characterized by absence of
CC       granulocytes, almost complete deficiency of lymphocytes in
CC       peripheral blood, hypoplasia of the thymus and secondary lymphoid
CC       organs, and lack of innate and adaptive humoral and cellular
CC       immunity, leading to fatal septicemia within days after birth. In
CC       bone marrow of individuals with reticular dysgenesis, myeloid
CC       differentiation is blocked at the promyelocytic stage, whereas
CC       erythro- and megakaryocytic maturation is generally normal.
CC       Inheritance is autosomal recessive. {ECO:0000269|PubMed:19043416,
CC       ECO:0000269|PubMed:19043417}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK2 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U39945; AAC52061.1; -; mRNA.
DR   EMBL; U84371; AAB41790.1; -; mRNA.
DR   EMBL; U54645; AAC13881.1; -; mRNA.
DR   EMBL; AB005621; BAC16747.1; -; mRNA.
DR   EMBL; AB005622; BAC16748.1; -; mRNA.
DR   EMBL; AY080899; AAL87027.1; -; mRNA.
DR   EMBL; AY080900; AAL87028.1; -; mRNA.
DR   EMBL; AK291676; BAF84365.1; -; mRNA.
DR   EMBL; AK295105; BAG58139.1; -; mRNA.
DR   EMBL; AK296863; BAG59426.1; -; mRNA.
DR   EMBL; AB451267; BAG70081.1; -; mRNA.
DR   EMBL; AB451394; BAG70208.1; -; mRNA.
DR   EMBL; AL020995; CAI19351.1; -; Genomic_DNA.
DR   EMBL; AL020995; CAI19352.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07484.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07486.1; -; Genomic_DNA.
DR   EMBL; BC009405; AAH09405.1; -; mRNA.
DR   EMBL; BC070127; AAH70127.1; -; mRNA.
DR   EMBL; BC090040; AAH90040.1; -; mRNA.
DR   CCDS; CCDS373.1; -. [P54819-2]
DR   CCDS; CCDS374.1; -. [P54819-1]
DR   PIR; G02248; G02248.
DR   PIR; JC5893; JC5893.
DR   RefSeq; NP_001186128.1; NM_001199199.1. [P54819-5]
DR   RefSeq; NP_001306068.1; NM_001319139.1.
DR   RefSeq; NP_001306069.1; NM_001319140.1. [P54819-6]
DR   RefSeq; NP_001616.1; NM_001625.3. [P54819-1]
DR   RefSeq; NP_037543.1; NM_013411.4. [P54819-2]
DR   UniGene; Hs.470907; -.
DR   PDB; 2C9Y; X-ray; 2.10 A; A=1-239.
DR   PDBsum; 2C9Y; -.
DR   ProteinModelPortal; P54819; -.
DR   SMR; P54819; -.
DR   BioGrid; 106707; 39.
DR   IntAct; P54819; 12.
DR   STRING; 9606.ENSP00000346921; -.
DR   BindingDB; P54819; -.
DR   ChEMBL; CHEMBL4938; -.
DR   DrugBank; DB00718; Adefovir Dipivoxil.
DR   DrugBank; DB01717; Bis(Adenosine)-5'-Pentaphosphate.
DR   DrugBank; DB00300; Tenofovir.
DR   iPTMnet; P54819; -.
DR   PhosphoSitePlus; P54819; -.
DR   SwissPalm; P54819; -.
DR   BioMuta; AK2; -.
DR   DMDM; 1708596; -.
DR   OGP; P54819; -.
DR   REPRODUCTION-2DPAGE; IPI00218988; -.
DR   UCD-2DPAGE; P54819; -.
DR   EPD; P54819; -.
DR   MaxQB; P54819; -.
DR   PaxDb; P54819; -.
DR   PeptideAtlas; P54819; -.
DR   PRIDE; P54819; -.
DR   DNASU; 204; -.
DR   Ensembl; ENST00000354858; ENSP00000346921; ENSG00000004455. [P54819-1]
DR   Ensembl; ENST00000373449; ENSP00000362548; ENSG00000004455. [P54819-2]
DR   GeneID; 204; -.
DR   KEGG; hsa:204; -.
DR   UCSC; uc001bwo.3; human. [P54819-1]
DR   CTD; 204; -.
DR   DisGeNET; 204; -.
DR   GeneCards; AK2; -.
DR   HGNC; HGNC:362; AK2.
DR   HPA; HPA018479; -.
DR   MalaCards; AK2; -.
DR   MIM; 103020; gene.
DR   MIM; 267500; phenotype.
DR   neXtProt; NX_P54819; -.
DR   OpenTargets; ENSG00000004455; -.
DR   Orphanet; 33355; Reticular dysgenesis.
DR   PharmGKB; PA24656; -.
DR   eggNOG; KOG3078; Eukaryota.
DR   eggNOG; COG0563; LUCA.
DR   GeneTree; ENSGT00830000128340; -.
DR   HOVERGEN; HBG000458; -.
DR   InParanoid; P54819; -.
DR   KO; K00939; -.
DR   OMA; CPKGIRA; -.
DR   OrthoDB; EOG091G06BH; -.
DR   PhylomeDB; P54819; -.
DR   TreeFam; TF300896; -.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   EvolutionaryTrace; P54819; -.
DR   GeneWiki; AK2; -.
DR   GenomeRNAi; 204; -.
DR   PRO; PR:P54819; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000004455; -.
DR   CleanEx; HS_AK2; -.
DR   ExpressionAtlas; P54819; baseline and differential.
DR   Genevisible; P54819; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; TAS:Reactome.
DR   GO; GO:0097226; C:sperm mitochondrial sheath; IEA:Ensembl.
DR   GO; GO:0004017; F:adenylate kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006172; P:ADP biosynthetic process; IEA:InterPro.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   CDD; cd01428; ADK; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03168; Adenylate_kinase_AK2; 1.
DR   InterPro; IPR006259; Adenyl_kin_sub.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR007862; Adenylate_kinase_lid-dom.
DR   InterPro; IPR028587; AK2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   Pfam; PF05191; ADK_lid; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01351; adk; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Kinase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; SCID; Transferase.
FT   CHAIN         1    239       Adenylate kinase 2, mitochondrial.
FT                                /FTId=PRO_0000423212.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.10}.
FT   CHAIN         2    239       Adenylate kinase 2, mitochondrial, N-
FT                                terminally processed.
FT                                /FTId=PRO_0000158917.
FT   NP_BIND      25     30       ATP. {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   NP_BIND      72     74       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   NP_BIND     100    103       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   NP_BIND     151    152       ATP. {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   REGION       45     74       NMPbind. {ECO:0000255|HAMAP-
FT                                Rule:MF_03168, ECO:0000269|Ref.17}.
FT   REGION      141    178       LID. {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   BINDING      46     46       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   BINDING      51     51       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   BINDING     107    107       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   BINDING     138    138       ATP. {ECO:0000269|Ref.17}.
FT   BINDING     142    142       ATP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   BINDING     175    175       AMP. {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   BINDING     186    186       AMP. {ECO:0000255|HAMAP-Rule:MF_03168}.
FT   BINDING     214    214       ATP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      58     58       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      62     62       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP6}.
FT   MOD_RES      93     93       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP6}.
FT   MOD_RES     133    133       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     181    181       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WTP6}.
FT   MOD_RES     195    195       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   DISULFID     42     92       {ECO:0000255|HAMAP-Rule:MF_03168,
FT                                ECO:0000269|Ref.17}.
FT   VAR_SEQ       1     48       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_002792.
FT   VAR_SEQ     135    142       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036503.
FT   VAR_SEQ     177    178       DD -> GL (in isoform 4).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_002793.
FT   VAR_SEQ     178    239       DNEKALKIRLQAYHTQTTPLIEYYRKRGIHSAIDASQTPDV
FT                                VFASILAAFSKATCKDLVMFI -> IGQAKRSFLRLAKISF
FT                                DVLIKKALA (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_002791.
FT   VAR_SEQ     179    239       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_002794.
FT   VAR_SEQ     232    239       CKDLVMFI -> S (in isoform 2 and isoform
FT                                5). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:19054851,
FT                                ECO:0000303|PubMed:9434148,
FT                                ECO:0000303|PubMed:9504408}.
FT                                /FTId=VSP_002790.
FT   VARIANT     103    103       R -> W (in RDYS; dbSNP:rs267606648).
FT                                {ECO:0000269|PubMed:19043416}.
FT                                /FTId=VAR_054630.
FT   VARIANT     165    165       D -> G (in RDYS; dbSNP:rs267606643).
FT                                {ECO:0000269|PubMed:19043416}.
FT                                /FTId=VAR_054631.
FT   VARIANT     209    209       A -> T (in dbSNP:rs12116440).
FT                                /FTId=VAR_050032.
FT   STRAND       16     21       {ECO:0000244|PDB:2C9Y}.
FT   HELIX        28     39       {ECO:0000244|PDB:2C9Y}.
FT   STRAND       42     45       {ECO:0000244|PDB:2C9Y}.
FT   HELIX        46     56       {ECO:0000244|PDB:2C9Y}.
FT   HELIX        59     69       {ECO:0000244|PDB:2C9Y}.
FT   HELIX        76     87       {ECO:0000244|PDB:2C9Y}.
FT   HELIX        90     92       {ECO:0000244|PDB:2C9Y}.
FT   STRAND       95    100       {ECO:0000244|PDB:2C9Y}.
FT   HELIX       105    117       {ECO:0000244|PDB:2C9Y}.
FT   STRAND      124    129       {ECO:0000244|PDB:2C9Y}.
FT   HELIX       132    140       {ECO:0000244|PDB:2C9Y}.
FT   TURN        146    148       {ECO:0000244|PDB:2C9Y}.
FT   STRAND      151    153       {ECO:0000244|PDB:2C9Y}.
FT   TURN        154    156       {ECO:0000244|PDB:2C9Y}.
FT   STRAND      166    168       {ECO:0000244|PDB:2C9Y}.
FT   HELIX       180    203       {ECO:0000244|PDB:2C9Y}.
FT   STRAND      207    211       {ECO:0000244|PDB:2C9Y}.
FT   HELIX       216    230       {ECO:0000244|PDB:2C9Y}.
SQ   SEQUENCE   239 AA;  26478 MW;  86FA94F9EE33629F CRC64;
     MAPSVPAAEP EYPKGIRAVL LGPPGAGKGT QAPRLAENFC VCHLATGDML RAMVASGSEL
     GKKLKATMDA GKLVSDEMVV ELIEKNLETP LCKNGFLLDG FPRTVRQAEM LDDLMEKRKE
     KLDSVIEFSI PDSLLIRRIT GRLIHPKSGR SYHEEFNPPK EPMKDDITGE PLIRRSDDNE
     KALKIRLQAY HTQTTPLIEY YRKRGIHSAI DASQTPDVVF ASILAAFSKA TCKDLVMFI
//
